Searched for
CELGENE
NATCO Pharma launches generic blood cancer treatment medicine in USNATCO Pharma has launched generic Pomalidomide capsules in the US. This drug treats blood and bone marrow cancer. It is a generic version o...- Natco Pharma, others sued in US for generic cancer drugThe company believes this matter is without merit, Natco Pharma said in a statement. Breckenridge is the abbreviated new drug application (...
- Sun Pharma gets USFDA nod to market generic medicationIn June 2021, Sun Pharma entered into a settlement with Celgene Corporation (Celgene) to resolve the patent litigation regarding its generi...
- Claims against Dr Reddy's over Revlimid in US dismissedDr Reddy's Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medic...
- Natco Pharma announces launch of first generic of top selling cancer drug RevlimidRevlimid had annual sales of $2.3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available i...
- Dr Reddy's gets FDA nod for generic Revlimid; enjoys 180 days exclusivity"We are pleased with the Agency's approval of Lenalidomide Capsules, 2.5 mg and 20 mg and being eligible for 180-day market exclusivity. We...
- Biocon inks patent litigation settlement pact with CelgeneThe company along with its subsidiaries has entered into a confidential settlement agreement with Celgene Corporation, a wholly-owned subsi...
- Sun Pharma settles patent litigation with Celgene Corporation for cancer drug RevlimidDrug major Sun Pharma has reached an agreement with Celgene Corporation, to resolve the patent litigation regarding generic version of Revl...
- Sun Pharma inches up as the company settles a patent litigationPursuant to the terms of the settlement, Celgene will grant Sun Pharma a licensc to Celgene’s patents required to manufacture and sell (sub...
- Natco Pharma gets American drug regulator's nod for generic cancer treatment drugNatco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...
- Shilpa Medicare gets tentative American health regulator nod for Apremilast tabletsThe company has received tentative approval from US Food and Drug Administration for its abbreviated new drug application (ANDA) Apremilast...
- Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules fro...
- Natco Pharma's Canadian unit signs pact with Celgene for cancer treatment drugNatco Pharma entered into an agreement with biopharmaceutical firm Celgene for Lenalidomide capsules, which is used to treat various types ...
- Dr Reddy's settles case with Celgene on cancer drugREVLIMID (Lenalidomide) is indicated for treatment for multiple myeloma (cancer).
- Glenmark, Particle Sciences to develop generic cancer drugThe partnership will develop and market a generic version of Celgene's ABRAXANE which is used in treatments of breast and lung cancers.
- Natco settles patent litigation with Celgene on cancer drugNatco and its US partner Allergan have settled a pending litigation with Celgene regarding generic Lenalidomide capsules used for treatment...
- USFDA approves DRL's Azacitidine for injectionAzacitidine is used to treat certain types of bone marrow cancers and blood cell disorders. Dr Reddy's Azacitidine for injection is availab...
- Natco Pharma open to settle cancer drug patent case with US coNatco Pharma Ltd on Friday did not rule out a settlement over the patent issue with Celgene Corp, which has said it would file a complaint ...
- DRL faces patent suit in US over allergy genericNYSE-listed Dr Reddy’s Laboratories (DRL) is embroiled in a fresh patent infringement row with US-based drug-discovery firm Albany Molecula...
- DRL seeks USFDA help to make cancer drug cloneUS-based biotech firm Celgene, the innovator, has declined to make the drug samples available to DRL for bio-equivalence studies.
Load More
